Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05613712
Other study ID # 38RC22.0355
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 11, 2023
Est. completion date February 11, 2024

Study information

Verified date March 2023
Source University Hospital, Grenoble
Contact Athan BAILLET, PU-PH
Phone 0476767082
Email abaillet@chu-grenoble.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes


Description:

In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date February 11, 2024
Est. primary completion date February 11, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Patient cohort : - men and women over 18 years of age - Informed volunteers who have consented to participate in the study - have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis - have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department - Cohort of referring physicians : - volunteers who received informed information and consented to participate in the study - be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes Exclusion Criteria: - Patient cohort : - psychiatric pathologies or history of behavioural disorders - persons referred to in articles L1121-5 to L1121-8 of the Public Health Code - persons under guardianship or curatorship - not affiliated to the social security system - minors - Refusal to participate by the patient and/or unreturned questionnaire - Cohort of referring physicians: - the physician is no longer the patient's referring physician - refusal of the doctor to participate and/or questionnaire not returned

Study Design


Intervention

Other:
Patients
Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up
Referring physician
Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Locations

Country Name City State
France CHU Grenoble Alpes Grenoble

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes 1 day
Secondary Elements limiting the good ambulatory follow-up, according to the patients Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up 1 day
Secondary Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes 1 day
See also
  Status Clinical Trial Phase
Completed NCT04327752 - Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
Recruiting NCT04334031 - Deployment o the Multidisciplinary Prospective Cohort Imminent N/A
Active, not recruiting NCT02332460 - Infusion Related Reactions in Patients Receiving Infliximab
Terminated NCT05323110 - Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers Phase 1